Threshold Pharmaceuticals to Present at the Cowen Health Care Conference
(firmenpresse) - SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 02/24/12 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Dr. Barry Selick, Threshold's Chief Executive Officer, is scheduled to present at the 32nd Annual Cowen Health Care Conference in Boston on Tuesday, March 6, 2012 at 10:00AM EST.
A live webcast of the presentation will be available under the Webcast section of the Company's Website at
Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of some hematologic malignancies. This approach offers broad potential to treat a variety of cancers. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs. For additional information, please visit our website ().
Joel A. Fernandes
Threshold Pharmaceuticals, Inc.
650.474.8273
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 24.02.2012 - 10:15 Uhr
Sprache: Deutsch
News-ID 118196
Anzahl Zeichen: 0
contact information:
Town:
SOUTH SAN FRANCISCO, CA
Kategorie:
Drugs
Diese Pressemitteilung wurde bisher 221 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Threshold Pharmaceuticals to Present at the Cowen Health Care Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Threshold Pharmaceuticals (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
